Scientists are researching if a drug that’s being tested to treat a skin condition can also help keep COVID-19 patients off ventilators. The drug, labeled as EDP1815, was being tested on psoriasis patients, but Dr. Reynold Panettieri, vice chancellor for translational medicine and science at Rutgers University, said it will now be tested on coronavirus patients who have pneumonia and inflammation of the lungs. To read the full article.
- Join NJ ACTS Workforce Core for Python Training on June 20th or June 22nd!
- Heather Howard Princeton Pulse Podcast – “Why Millions of Americans May Lose Their Health Insurance Coverage”
- New NJACTS Publication
- Join NJ ACTS for NIH Grant Bootcamp on July 11th!
- Senior Internships with Rutgers Innovation Ventures – Apply Now!